πŸ‡ΊπŸ‡Έ FDA
Patent

US 6620825

Adenosine A3 receptor antagonists

expired A61KA61K31/4436A61K31/4439

Quick answer

US patent 6620825 (Adenosine A3 receptor antagonists) held by Takeda Chemical Industries Ltd. expires Mon Sep 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Takeda Chemical Industries Ltd.
Grant date
Tue Sep 16 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 11 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
12
CPC classes
A61K, A61K31/4436, A61K31/4439, A61P, A61P11/00